AzTrials
AzTrials

HypertensionNCT04899648

Hypertension Prevention Program, Implementation and Scale up- a Hybrid Effectiveness Implementation Study

A study testing Behavioral Intervention Group in people with Hypertension and Dietary Modification, run by University of Washington.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This is an effectiveness-implementation study to assess the effectiveness of a peer-led multi-component lifestyle program that will aim to lower BP among pre-hypertensive individuals in Nepal. Read more about this study

Who is it for?
Ages 18 to 60 years
What is being tested?
Behavioral Intervention Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
500 participants
Where
No sites listed yet
Study dates
30 May 2021to 30 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Full-time employees who work a minimum of 40 hours per week as appointed by the school within the age group of 18-60 including both male and female.

Who cannot join

  • Pregnant females, Participants below 18 years or and above 60.

Trial locations and contacts

No sites are listed yet.

Julia Dettinger, MPH contact

206-221-1041

jcdettin@uw.edu

About this study

Official title: Hypertension Prevention Program, Implementation and Scale up- a Hybrid Effectiveness Implementation Study in Schools of Dhulikhel and Banepa

This is an effectiveness-implementation study to assess the effectiveness of a peer-led multi-component lifestyle program that will aim to lower BP among pre-hypertensive individuals in Nepal. The program will aim to encourage weight loss, improve diet (using a DASH diet), lower sodium intake, encourage only moderate alcohol intake among drinkers, and encourage more physical activity through peers.

Read the detailed description

Hypertension is a serious medical condition and can increase the risk of heart, brain, kidney and other diseases. It is a major cause of premature death worldwide, with upwards of 1 in 4 men and 1 in 5 women - over a billion people - having the condition. The burden of hypertension is felt disproportionately in low- and middle-income countries, where two-thirds of cases are found, largely due to increased risk factors in those populations in recent decades Pre-hypertension, defined as systolic blood pressure (BP) of 120-139 mmHg or diastolic BP of 80-89 mmHg, is a precursor to hypertension, and is associated with excess morbidity and deaths from cardiovascular diseases (CVD). Hence, the reduction of BP to optimal levels is a major public health priority. Although clinical trials have shown that pharmacotherapy lowers BP among pre-hypertensives; it has been argued that pharmacotherapy is not reasonable because the absolute risk in patients without other CVD risk factors is low and pharmacotherapy is costly. Lifestyle modifications have proven to reduce BP, and are also useful to prevent other chronic diseases. Major lifestyle modifications shown to lower BP include weight loss; reduced sodium intake; regular aerobic physical activity; moderate alcohol drinking; the Dietary Approach to Stop Hypertension diet - a diet rich in fruits, vegetables, low-fat dairy products, potassium and calcium, and reduced dietary cholesterol, saturated and total fats. Combinations of two or more lifestyle modifications may have even better results. However, most of the studies have focused on one or two lifestyle interventions and are tested in efficacy trials in a clinical setting. Therefore, there is a major gap in the evidence for the effectiveness of a community-based multi-component intervention on BP reduction. In addition, it is not clear how such an intervention would be scaled up to the general population in low-and-middle-income countries, where the burden of hypertension and CVD is the highest.

To address this gap, the investigators propose to conduct an effectiveness-implementation study to assess the effectiveness of a peer-led multi-component lifestyle program that will aim to lower BP among pre-hypertensive individuals in Nepal. The program will aim to encourage weight loss, improve diet (using a DASH diet), lower sodium intake, encourage only moderate alcohol intake among drinkers, and encourage more physical activity through peers. Peer education can be as effective as using health professionals and is a cost-effective and sustainable method for lifestyle modification. The peer-education approach is driven by social learning theory, emphasizing credibility, role modeling, empowerment, and reinforcement which contrasts with the delivery of lifestyle modification advice in the usual clinical setting. While implementing the peer-led multi-component lifestyle intervention, the investigators will collect information on factors affecting the delivery of the program and the potential for scaled-up implementation in a real-world situation. The feasibility and scalability of such programs in a real-life setting have not been studied. Besides, there are three key challenges to manage pre-hypertension and hypertension in low-and middle-income countries (LMICs). First, the pre-hypertensive population is considered non-diseased; hence they are not in contact with the health system. Second, even though the efficacy of lifestyle modifications has been proven, sustainable lifestyle modifications in the general population are difficult to achieve due to the complexity of behavioral change. And third, the health system in LMICs is already worn out due to the double burden of disease, and inadequate financing and human resources. To address this massive challenge in an LMIC such as Nepal, a cost-effective, community-based, sustainable, and scalable intervention is required. The proposed study will establish evidence for a new model to lower BP in a community setting, by determining the effectiveness of the peer-led multi-component program and informing the success of implementation and scalability. This model will provide a valuable resource for making recommendations and dissemination plans to implement and sustain lifestyle interventions for lowering BP at the community level.

As such, the objectives of this study are:

  1. To measure the effectiveness of the peer-led online multi-component lifestyle program on reducing BP among the school employees of Dhulikhel and Banepa, Nepal. The investigators will compare the change in systolic BP at twelve months between the peer-led multi-component program group and usual care group using a community-based cluster randomized control trial.
  2. To measure the success of implementation and inform the scalability of the peer-led multi-component lifestyle program. The investigators will evaluate (a) program adoption by assessing changes in weight, diet, and physical activity behaviors among lifestyle intervention participants; (b) fidelity to the program design by assessing activities of peer-educators; and (c) acceptability of the program through (i) in-depth, semi-structured interviews with lifestyle intervention program dropouts; and (ii) focus group discussions with lifestyle intervention program participants.
  3. To assess the impact of Covid-19 in hypertension management in context to the mental wellbeing of hypertensive patients. The investigators will measure the impact of Covid-19 on the mental health of a participant by measuring their anxiety and depression levels through a questionnaire scale.

After identification of possible participants, the principal investigator and/or the research assistants would make formal phone calls to the principals of the different educational institutes to describe the research project. The principals of the educational institutes are, then, sent information sheets and other informational materials regarding the project via email. Then, after the approval of the principal, all the staff of the educational institutions would be sent an information sheet and other information regarding the project. After everyone is informed, a formal zoom or google meet appointment would be made with all the staff of the educational institute. In this manner, the study participants would be recruited and screened.

After 500 participants are selected from various educational institutes, their baseline information will be collected which would include aspects of their demography, physical activity, behavioral history like smoking and alcohol consumption, diet recall, mental health status and anthropometric measurements. This will all take place in the first 3 months of the study. All of this information will be collected via an online survey. As for the anthropometric measurements, the investigators will have provided anthropometric instruments like Digital Blood Pressure Machine, Digital Weighing Scale and Mechanical Measuring tape, to each educational institute and also provided them with World Health Organization Guidelines to use those instruments. Using the tools provided by the investigators, the study participants will measure their anthropometric data themselves when they are in their workplace. This information is then sent along with their other information while filling up the online survey. After that, a computer-generated randomization process will be carried out after which 250 participants will be selected for the intervention process.

Control Group: The remaining 250 Participants in the control group would not get exercise and nutritional classes. But they will all get the study and educational material regarding hypertension prevention after the end of the study.

Behavioral Classes: Participants (n=250) who are selected for the Behavioral Intervention classes will be connected with the study team for 20 minutes video, 20 minutes of discussion and 20 minutes of exercise every week. It would include 16 core sessions weekly during the next four months of the program followed by 1 month maintenance sessions. Each core session will last 1 hour every week. The audio and video of the sessions for some intervention groups will be recorded. These Participants would also be reimbursed Nrs. 50 for the data package 16 times.

Peer Leader: Among the selected participants from the Intervention group, 10% of the participants would be appointed peer leaders. The peer leaders will go through health education classes via online platforms using various videos and presentations. The peer leaders will also be paired with the professional health educators from the study staff and will be informed about aspects like Diabetes Prevention Program Curriculum along with dieting and exercise classes. Professional health educators will train the peer educators and provide online supervision as well. The health educators will also assess the classes taken by peer leaders to the rest of the participants and provide necessary feedback and motivation. Behavior intervention will be comprised of extensive education sessions, group counseling and goal setting and monitoring exercises based on the diabetes prevention program developed by India Works. Peer Leader will conduct 16 session classes for the remaining participants in the intervention group virtually. Peer Leader will measure Blood Pressure, Height and weight of the Participants once a month from the Intervention Group.

Endline: This survey will be done for all the participants both in the control and intervention groups. This would take 15-20 minutes. Some of the questions from the baseline survey will be filled by the participants. (about daily activities, cigarettes and alcohol intake) Height, weight, blood pressure will be accessed by themselves or their designated peer leader. Questions about 24 hours diet, physical activities will be asked by the research assistants through online platforms like zoom or viber.

Being tested
Behavioral Intervention Group
Keywords
Hypertension Prevention
Medical subject headings
Hypertension, Health Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Behavioral Intervention GroupBehavioural

    Behavioral intervention: (a) form groups and choose peer leaders; (b) train peer leaders on 16 core classes based on diabetes prevention program curriculum; (c) support and motivate peer leaders to lead intervention in their group; (d) monitoring of the interventions.

Study groups in NCT04899648
Study groupRoleWhat they receive
Behavioral InterventionExperimentalReceives nutrition and exercise intervention classes
Receives: Behavioral: Behavioral Intervention Group
Control GroupNo interventionDoes not receive any intervention classes

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Systolic Blood pressure

    An average of three measurements, mmHg continuous variable

    Measured: Four months

  2. Diastolic Blood pressure

    An average of three measurements, mmHg continuous variable

    Measured: Four months

Secondary outcomes (2)
  1. Body Mass Index

    Change in Weight to Height ratio based on BMI

    Measured: Four Months

  2. Healthy food intake

    Intake of whole grains, fruits and vegetables based on 24 hour diet recall

    Measured: Four Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 May 2021
  2. Study start30 May 2021 (estimated)
  3. Primary completion30 Dec 2021 (estimated)
  4. Study completion30 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04899648
Sponsor's protocol ID
STUDY00012777
Status last verified
May 2021
First submitted
19 May 2021
Last updated
26 May 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Behavioral Intervention Group in people with Hypertension and Dietary Modification, run by University of Washington.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 May 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Julia Dettinger, MPH (206-221-1041, jcdettin@uw.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Systolic Blood pressure (time frame: Four months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in